§° Goldsite

Goldsite Diagnostics Inc., §à§ã§ß§à§Ó§Ñ§ß§ß§Ñ§ñ §Ó 1999 §Ô§à§Õ§å, §ñ§Ó§Ý§ñ§Ö§ä§ã§ñ §Ó§Ö§Õ§å§ë§Ú§Þ §Ü§Ú§ä§Ñ§Û§ã§Ü§Ú§Þ §á§â§à§Ú§Ù§Ó§à§Õ§Ú§ä§Ö§Ý§Ö§Þ §Õ§Ú§Ñ§Ô§ß§à§ã§ä§Ú§é§Ö§ã§Ü§Ú§ç §ã§â§Ö§Õ§ã§ä§Ó, §ã§á§Ö§è§Ú§Ñ§Ý§Ú§Ù§Ú§â§å§ð§ë§Ú§Þ§ã§ñ §ß§Ñ §å§ã§ä§â§à§Û§ã§ä§Ó§Ñ§ç §Ú §â§Ö§Ñ§Ô§Ö§ß§ä§Ñ§ç §Õ§Ý§ñ §Õ§Ú§Ñ§Ô§ß§à§ã§ä§Ú§Ü§Ú in vitro.§µ§Ø§Ö §Ò§à§Ý§Ö§Ö 20 §Ý§Ö§ä §Þ§í §â§Ñ§Ù§â§Ñ§Ò§Ñ§ä§í§Ó§Ñ§Ö§Þ §Ú §á§â§à§Ú§Ù§Ó§à§Õ§Ú§Þ §Ó§í§ã§à§Ü§à§Ü§Ñ§é§Ö§ã§ä§Ó§Ö§ß§ß§å§ð §á§â§à§Õ§å§Ü§è§Ú§ð: §à§ä §á§Ö§â§Ó§à§Ô§à §Ó §¬§Ú§ä§Ñ§Ö §ã§á§Ö§è§Ú§æ§Ú§é§Ö§ã§Ü§à§Ô§à §Ñ§ß§Ñ§Ý§Ú§Ù§Ñ§ä§à§â§Ñ §Ò§Ö§Ý§Ü§à§Ó §Õ§à §ã§Ñ§Þ§à§Ô§à §Ú§ß§ß§à§Ó§Ñ§è§Ú§à§ß§ß§à§Ô§à §ß§Ö§æ§Ö§Ý§à§Þ§Ö§ä§â§Ñ GPP-100 §Ú§Ù §ß§Ñ§ê§Ú§ç §Ú§Ù§Ó§Ö§ã§ä§ß§í§ç §ß§Ñ§Ò§à§â§à§Ó §Õ§Ý§ñ §ß§Ö§æ§Ö§Ý§à§Þ§Ö§ä§â§Ú§Ú (§ß§Ñ§á§â§Ú§Þ§Ö§â, §Ý§å§é§ê§Ú§Û §Ó §¬§Ú§ä§Ñ§Ö CRP, §ã§Ö§â§ä§Ú§æ§Ú§è§Ú§â§à§Ó§Ñ§ß§ß§í§Û NGSP HbA1c §Ú §ä. §Õ.). §Ü§à §Ó§ã§Ö§Þ §ï§ä§Ú§Þ §ß§Ú§Ü§à§Ô§Õ§Ñ §ß§Ö §ã§Ü§à§Þ§á§â§à§Þ§Ö§ä§Ú§â§à§Ó§Ñ§ß§ß§í§Þ §â§Ö§Ñ§Ô§Ö§ß§ä§Ñ§Þ CLIA, §Ò§Ú§à§ç§Ú§Þ§Ú§Ú §Ú §£§¿§¨§·.§³§à §Ó§ã§Ö§Þ§Ú §á§â§à§Õ§å§Ü§ä§Ñ§Þ§Ú §®§Ñ§â§Ü§Ú§â§à§Ó§Ü§Ñ CE, §ß§Ñ§ê§Ö §á§â§Ú§ã§å§ä§ã§ä§Ó§Ú§Ö §ß§Ñ §â§í§ß§Ü§Ö §Ó §ß§Ñ§ã§ä§à§ñ§ë§Ö§Ö §Ó§â§Ö§Þ§ñ §â§Ñ§ã§á§â§à§ã§ä§â§Ñ§ß§ñ§Ö§ä§ã§ñ §ã§à §Ó§ã§Ö§Ô§à §¬§Ú§ä§Ñ§ñ §ß§Ñ §Ò§à§Ý§Ö§Ö §é§Ö§Þ 60 §ã§ä§â§Ñ§ß, §Ó§Ü§Ý§ð§é§Ñ§ñ §ª§ä§Ñ§Ý§Ú§ð, §²§å§Þ§í§ß§Ú§ð, §ª§ß§Õ§Ú§ð, §º§Ó§Ö§Û§è§Ñ§â§Ú§ð, §´§å§â§è§Ú§ð, §®§Ñ§Ý§Ñ§Û§Ù§Ú§ð §Ú §ä. §Õ., Goldsite §â§Ñ§ã§ê§Ú§â§ñ§Ö§ä §ã§Ó§à§Ö §á§â§Ú§ã§å§ä§ã§ä§Ó§Ú§Ö §Ú §ã§ä§Ñ§ß§à§Ó§Ú§ä§ã§ñ §Þ§Ú§â§à§Ó§í§Þ §Ò§â§Ö§ß§Õ§à§Þ.